Skip to content

The added value of [G]OLD: An evaluation study of the effects of screening elderly people in order to detect frailty at an early stage. (In Dutch: De waarde van [G]OUD: Een evaluatiestudie naar de effecten van de consultatiefunctie voor ouderen.)

The added value of [G]OLD: An evaluation study of the effects of screening elderly people in order to detect frailty at an early stage. (In Dutch: De waarde van [G]OUD: Een evaluatiestudie naar de effecten van de consultatiefunctie voor ouderen.)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25845
Enrollment
1716
Registered
2011-02-07
Start date
2010-05-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty, health-related quality of life, disability (in Dutch: kwetsbaarheid, gezondheidsgerelateerde kwaliteit van leven, zelfredzaamheid)

Interventions

In total, 14 general practices will participate in the intervention group and 13 general practices will participate in the control group. All participating general practices randomly select community-
2. Discuss results with the GP. The results of the [G]OLD-instrument, as well as the patient’s needs and wishes, determine whether follow-up actions regarding certain problems are needed. These action
3. Formulate – if required – a care and treatment plan together with the patient
4. Refer patient to care and/or well-being facilities (if applicable)
5. Monitor and coordinate care and follow-up. The need for and frequency of follow-up contacts strongly depends on the type of problems or complaints that deserve attention according to the care and t

Sponsors

Maastricht University Medical Center (MUMC+)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 75 years and over, either sex; 2. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Not living independently; 2. On a waiting list for admission to a nursing home or home for the elderly; 3. Under close medical supervision (chemotherapy, chronic haemodialysis or other therapies posing a high burden on the person); 4. Terminally ill.

Design outcomes

Primary

MeasureTime frame
The primary outcome measures are health-related quality of life, measured by the RAND-36, and disability, assessed using the Groningen Activity Restriction Scale (GARS). Sample size calculations are based on the RAND-36.

Secondary

MeasureTime frame
1. Attitude towards ageing (subscale attitude toward own ageing from the PGC Morale Scale); 2. Health care utilization (number of contacts with different health care providers, e.a., GP consultations, hospital admission); 3. Admission to nursing home or home for the elderly (number of admissions and time to admission from T0 to T3); 4. Mortality (number of deaths from T0 to T3).

Contacts

Public ContactMandy Stijnen

Postbus 616

mandy.stijnen@maastrichtuniversity.nl+31 (0)43 3882295

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)